Abstract:Background The relationship between gut microbiota and in vivo coronary plaque characteristics has not been reported. This study was conducted to investigate the relationship between gut microbiota and coronary plaque characteristics in patients with coronary artery disease. Methods and Results Patients who underwent both optical coherence tomography and intravascular ultrasound imaging and provided stool and blood specimens were included. The composition of gut microbiota was evaluated using 16S rRNA sequencing. A total of 55 patients were included. At the genus level, 2 bacteria were associated with the presence of thin‐cap fibroatheroma, and 9 bacteria were associated with smaller fibrous cap thickness. Among them, some bacteria had significant associations with inflammatory/prothrombotic biomarkers. Dysgonomonas had a positive correlation with interleukin‐6, Paraprevotella had a positive correlation with fibrinogen and negative correlation with high‐density lipoprotein cholesterol, Succinatimonas had positive correlations with fibrinogen and homocysteine, and Bacillus had positive correlations with fibrinogen and high‐sensitivity C‐reactive protein. In addition, Paraprevotella , Succinatimonas , and Bacillus were also associated with greater plaque volume. Ten bacteria were associated with larger fibrous cap thickness. Some were associated with protective biomarker changes; Anaerostipes had negative correlations with trimethylamine N‐oxide, tumor necrosis factor α, and interleukin‐6, and Dielma had negative correlations with trimethylamine N‐oxide, white blood cells, plasminogen activator inhibitor‐1, and homocysteine, and a positive correlation with high‐density lipoprotein cholesterol. Conclusions Bacteria that were associated with vulnerable coronary plaque phenotype and greater plaque burden were identified. These bacteria were also associated with elevated inflammatory or prothrombotic biomarkers. Registration URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000041692. Nonstandard Abbreviations and Acronyms EEM external elastic membrane FCT fibrous cap thickness LDA linear discriminant analysis PAV percent atheroma volume PB plaque burden SAP stable angina pectoris SCFA short‐chain fatty acid TAV normalized normalized total atheroma volume TCFA thin‐cap fibroatheroma TMAO trimethylamine N‐oxide Clinical Perspective What Is New? In the current study, we investigated the detailed relationship between gut microbiota and coronary plaque characteristics using both optical coherence tomography and intravascular ultrasound. Bacteria associated with favorable and unfavorable plaque characteristics were identified. Some bacteria associated with vulnerable plaque features also had significant associations with inflammatory/prothrombotic biomarkers. What Are the Clinical Implications? Gut microbiota may play an important role in vulnerable plaque formation. Large‐scale studies with long‐term follow‐up are required to confirm the findings of this pilot study. Once the current findings are confirmed, the microbiome may be used not only for risk stratification but also for identification of potential therapeutic targets. Recently, the role of gut microbiota in various health conditions has been gaining attention. 1 , 2 , 3 Dysbiosis of gut microbiota and microbial metabolites, such as trimethylamine N‐oxide (TMAO) and short‐chain fatty acid, were reported to have strong associations with cardiovascular diseases such as atherosclerosis, heart failure, and hypertension. 1 <sup -Abstract Truncated-

Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort

Streptococcus species abundance in the gut is linked to subclinical coronary atherosclerosis in 8,973 participants from the SCAPIS cohort

Oral microbiota in patients with atherosclerosis

Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target

The Gut Microbiome in Atherosclerotic Cardiovascular Disease.

Alterations of gut microbiome profiles as potential markers in patients developing acute coronary syndrome

Metagenomic Analysis to Uncover the Subgingival and Atherosclerotic Plaque Microbiota in Patients with Coronary Artery Disease

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

Gut Microbiota Community Shift with Severity of Coronary Artery Disease

The gut microbiome in subclinical atherosclerosis: a population-based multiphenotype analysis

The Gut Microbiome and Serum Metabolome are Altered and Interrelated in Patients with Intracranial Atherosclerotic Stenosis

Microbial composition of atherosclerotic plaques

Gut Microbiota and Coronary Plaque Characteristics.

Characterization of Salivary Microbiota in Patients with Atherosclerotic Cardiovascular Disease: A Case-Control Study

Gut Microbiome Alterations in Patients With Carotid Atherosclerosis

Oral Disease and Atherosclerosis May Be Associated with Overlapping Metabolic Pathways

Alterations in the Salivary Microbiome and Metabolism in Patients With Carotid Atherosclerosis from Rural Northeast China

Detection of periodontal microorganisms in coronary atheromatous plaque specimens of myocardial infarction patients: A systematic review and meta-analysis

Altered Salivary Microbiota Profile in Patients with Abdominal Aortic Aneurysm

Alterations in the Gut Microbiome and Metabolism with Coronary Artery Disease Severity.

Unveiling the oral-gut connection: chronic apical periodontitis accelerates atherosclerosis via gut microbiota dysbiosis and altered metabolites in apoE-/- Mice on a high-fat diet